Hamid Bassiri

Assistant Professor

University of Pennsylvania Perelman School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hamid Bassiri is an Assistant Professor at the University of Pennsylvania Perelman School of Medicine in the United States. His research focuses on cytokine release syndrome, multisystem inflammatory syndrome in children, and the immune responses related to pediatric diseases, particularly in the context of CAR T-cell therapy and COVID-19. He has contributed to several notable publications that address the treatment and diagnostic challenges associated with these conditions.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Grant Schulert

Assistant Professor

University of Cincinnati College of Medicine

UNITED STATES

View details

Kate Kernan

University of Pittsburgh

UNITED STATES

View details

Caroline Diorio

University of Pennsylvania Perelman School of Medicine

UNITED STATES

View details

Yaroslav Kaminskiy

Northwestern University

UNITED STATES

View details

Michele P. Lambert

UNITED STATES

View details

David Teachey

Professor

Children's Hospital of Philadelphia

UNITED STATES

View details

Kandace Gollomp

Assistant Professor

Children's Hospital of Philadelphia

UNITED STATES

View details

Scott W. Canna

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hamid Bassiri

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective

Skewed Cytokine Responses Rather Than the Magnitude of the Cytokine Storm May Drive Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19

Diagnostic Challenges in Pediatric Hemophagocytic Lymphohistiocytosis

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1

Collaborators (8)

Grant Schulert

Kate Kernan

Caroline Diorio

Yaroslav Kaminskiy

Michele P. Lambert

David Teachey

Kandace Gollomp

Scott W. Canna

Make your next move.